{"schema_version":"secwatch.filing_event.v1","accession":"0001110803-26-000155","form_type":"8-K","ticker":"ILMN","cik":"0001110803","company_name":"ILLUMINA, INC.","filed_at":"2026-07-30T20:07:16+00:00","discovered_at":"2026-07-30T20:08:00.255382+00:00","generated_at":"2026-07-30T20:08:17.685189+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Illumina Q2 revenue $1.16B (+9.5% YoY), raises FY2026 guidance on strong NovaSeq X demand","bullets":["Revenue $1.16B, up 9.5% YoY; organic growth 8.1% ex-currency, acquisitions, and China.","GAAP diluted EPS $1.35, non-GAAP $1.31; GAAP operating margin 21.1%, non-GAAP 22.5%.","FY2026 guidance raised: revenue $4.60-$4.64B, non-GAAP EPS $5.30-$5.40 (prior $5.15-$5.30).","Free cash flow $162M; cash and short-term investments $1.17B at quarter end.","CEO cites strong momentum; ROW organic growth guidance raised to >5% from 2%-4%."],"urls":{"canonical":"https://secwatch.observer/filing/0001110803-26-000155","json":"https://secwatch.observer/filing/0001110803-26-000155.json","markdown":"https://secwatch.observer/filing/0001110803-26-000155.md","text":"https://secwatch.observer/filing/0001110803-26-000155.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1110803/000111080326000155/0001110803-26-000155-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1110803/000111080326000155/ilmn-20260730.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-30T20:08:17.685189+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}